SYN-AKE Peptide 1 kg

Syn-Ake peptide ingredient for serum formulations and aqueous systems with muscle-relaxation inspired mechanism

Syn-Ake is a synthetic peptide used in cosmetic formulations as a water-phase active designed to influence surface-level muscle contraction behavior. It is applied in serums, gels, creams and ampoule solutions where controlled integration of peptide structures into aqueous systems is required. The ingredient is used in cosmetic development, SPA applications, professional formulations and laboratory systems focused on stability and reproducible performance.

From a technical standpoint, Syn-Ake is a peptide engineered to mimic certain signal transmission pathways associated with muscle contraction processes. It is not a pharmaceutical substance and is not used in injectable applications. Within formulations, it functions as a water-dispersible component that requires controlled pH and temperature conditions to maintain stability.

In cosmetic systems, Syn-Ake is incorporated into formulations designed to support a smoother visual appearance of the skin surface. It is typically combined with hydration-supporting materials, polysaccharides, amino acid systems and other peptide complexes to create balanced aqueous formulations. In professional products, it is often used in concentrated serums and lightweight gel structures.

The mechanism of Syn-Ake is associated with reducing the intensity of signal transmission involved in surface-level muscle contraction. In topical formulations, this can be observed as a temporary reduction in the visibility of dynamic expression lines due to decreased micro-movement activity. When compared to botulinum toxin, which is used in medical injectable procedures and acts on deeper neuromuscular pathways, Syn-Ake operates only at the cosmetic level through topical application and does not interact with systemic biological processes.

The comparison with botox is commonly used to describe the conceptual mechanism, but it is important to distinguish their nature and application. Botulinum toxin is a regulated pharmaceutical substance administered through injections, while Syn-Ake is a cosmetic peptide applied topically within formulations. It is not a replacement for injectable procedures and is used as part of routine cosmetic products.

In formulation practice, Syn-Ake is added during the cooling phase after the primary aqueous or gel base has been prepared. It is compatible with hyaluronic acid, niacinamide, panthenol, beta glucan and mild preservation systems. High processing temperatures should be avoided to maintain peptide stability.

Usage level is defined by technical specifications and adjusted by the formulator depending on formulation goals.

Example formulation: Peptide serum for surface smoothing
Purified water 69 ml
Syn-Ake 4 g
Butylene glycol 5 g
Hydrolyzed collagen solution 10 ml
Trehalose 3 g
Allantoin 2 g
Preservative 1 g
pH adjuster 6 g

Process: butylene glycol and trehalose are dissolved in purified water under mixing until a uniform base is formed. Hydrolyzed collagen solution and allantoin are then incorporated. After the system cools, Syn-Ake is added with gentle mixing. Preservative is introduced and pH is adjusted. The formulation is mixed until clear and stable before filling.

Example formulation: Gel-based peptide system
Purified water 65 ml
Syn-Ake 4 g
Propanediol 5 g
Hydroxyethylcellulose 1 g
Caffeine solution 10 ml
Betaine 3 g
Preservative 1 g
pH adjuster 11 g

Process: hydroxyethylcellulose is dispersed in propanediol and introduced into water under mixing to form a gel structure. The caffeine solution and betaine are added. During the cooling stage, Syn-Ake is incorporated with gentle agitation. Preservative is added and pH is adjusted. The system is mixed until homogeneous and stabilized.

Syn-Ake is used in cosmetic formulations as a peptide component designed for controlled surface-level activity. It supports stable performance in aqueous systems and is integrated into modern skincare formulations that focus on visual smoothing without injectable intervention.